Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1993
03/10/1993EP0530311A1 The use of phenylpropanolamine as a mucus secretagogue in the upper airways
03/10/1993EP0530286A1 Process for the stereoselective preparation of phenylisoserin derivatives.
03/10/1993EP0530285A1 Process for the enantioselective preparation of phenylisoserin derivatives.
03/10/1993EP0530268A1 Process for the preparation of 7-alpha-alkoxycephem derivatives.
03/10/1993EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof
03/10/1993EP0530242A1 Compounds
03/10/1993EP0530207A1 Imidazopyridine paf antagonists
03/10/1993EP0530198A1 Heterocyclic compounds as aldose reductase inhibitors
03/10/1993EP0525033A4 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5h)-furanones as anti-inflammatory agents
03/10/1993EP0525002A4 2(5h)-furanones substituted in the 3 position, as ca?2+ channel antagonists and anti-inflammatory agents
03/10/1993EP0524979A4 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents
03/10/1993EP0521871A4 Alternative enzyme substrates as deodorants
03/10/1993EP0519983A4 Use of ketorolac for treatment of periodontal disease
03/10/1993EP0514437A4 Branched alkyl esters of 4-bis (chloroethyl) aminophenyl-alkyl carboxylic acids for treatment of primary and metastatic tumors of the lymphatic system, and of cancers of the breast and ovaries
03/10/1993EP0455648B1 Dosage form for administering calcium antagonist
03/10/1993EP0447414B1 Use of minoxidil for wound healing
03/10/1993EP0439570B1 A novel use of beta-receptor blocking agents for treatment of menieres' disease
03/10/1993EP0365519B1 Topical prodrugs for treatment of acne and skin diseases
03/10/1993EP0364490B1 A method for detecting a retinoblastoma gene defect in tumors using a retinoblastoma gene probe
03/10/1993EP0312581B1 Pharmaceutical sustained release matrix and process
03/10/1993CN1069741A Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
03/10/1993CN1069733A 6-Oxo-azepinoindole and process for producing same and intermediate and application as pharmaceutical
03/10/1993CN1069732A 1,7-Condensed 2-(piperazinealkyl)-indole derivatives and process for preparing same and intermediate and pharmaceutical containing same
03/10/1993CN1069731A Dibenz |b,f¨ |1,4¨ oxazepin-11(10H)-ones for multidrug resistance reversing agents
03/10/1993CN1069727A Therapeutic amides
03/10/1993CN1069726A Medicaments
03/10/1993CN1069724A New purpose of sinapine for preventing radiation injury to animals and plants
03/10/1993CN1069722A 4-Demethoxy-4-amino daunomycinone and process for preparing same
03/10/1993CN1069651A Production method of quick effect wound-healing
03/10/1993CA2077732A1 Heterocyclic derivatives
03/10/1993CA2077638A1 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n- alkynylheteroarylmacrolides having immunosuppressive activity
03/10/1993CA2077611A1 Antibiotic ll-e19020 zeta and ll-e19020 eta
03/10/1993CA2077610A1 Recovery process for antibiotics ll-e19020 alpha and beta
03/10/1993CA2077597A1 Antibiotic ll-e19020 alpha 1
03/10/1993CA2077583A1 Antibiotic ll-e19020 gamma
03/10/1993CA2077331A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosuppressive activity
03/10/1993CA2074419A1 1,4-dihydropyridines with paf-antagonistic activity
03/10/1993CA2050948A1 5-benzyl substituted-benzimidazo-line-2-thion derivatives and a process for preparing the same
03/09/1993US5192808 Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
03/09/1993US5192807 Siderophores as antiparasitic agents
03/09/1993US5192806 Thromboxane A2 antagonist
03/09/1993US5192805 Use of acetyl l-carnitine in the therapeutic treatment of coma
03/09/1993US5192799 Coumaran group containing amine compounds and their acid addition salts and quaternary ammonium salts and the use thereof as anti arrhythmic agents and as psychotropic agents
03/09/1993US5192797 Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
03/09/1993US5192795 Cognition activators
03/09/1993US5192790 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis
03/09/1993US5192788 Porphyrin antiviral compositions
03/09/1993US5192785 Sulfamates as antiglaucoma agents
03/09/1993US5192784 Physical and chemical stability
03/09/1993US5192780 Methods using antiallergics and antihistamines
03/09/1993US5192775 New aminomethylpiperidine compounds
03/09/1993US5192773 Immunosuppressive compounds
03/09/1993US5192772 Therapeutic agents
03/09/1993US5192771 (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
03/09/1993US5192770 Serotonergic alpha-oxoacetamides
03/09/1993US5192765 Smooth muscle, bowel, bladder and airway diseases
03/09/1993US5192763 Antiischemic agents, anticonvulsants
03/09/1993US5192762 Use of bridged tricyclic amine derivatives as anti-ischemic agents
03/09/1993US5192761 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-diones, pharmaceutical compositions
03/09/1993US5192760 3-carbalkoxyamino-5-(alpha-aminopropionyl)-5H-dibenz[b,f]azepines and method for their making
03/09/1993US5192759 Derivatives of 1,2,3,4-tetrahydronaphtylamine endowed with nootropic activity and pharmaceutical compositions containing same
03/09/1993US5192756 Aminosterol antibiotic
03/09/1993US5192754 Treatment with steroids
03/09/1993US5192753 Anti-rheumatoid arthritic drugs in the treatment of dementia
03/09/1993US5192752 Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
03/09/1993US5192751 Administering a decahydroisoquinoline derivative
03/09/1993US5192750 Using N-acetylglucosamine for treatment of allergies
03/09/1993US5192740 Compositions and methods for improving cold tolerance in animals and humans
03/09/1993US5192671 Fermentation with Saccharopolyspora
03/09/1993US5192664 Parathyroid hypertensive factor, antibodies and uses thereof
03/09/1993US5192577 Nutritional composition and a process for its production
03/09/1993US5192551 Neutral glycolipid as an adsorbent for enteric viral pathogens
03/09/1993US5192544 Cosmetic or pharmaceutical composition for topical application containing at least one retinoid derivative and at least one pyrimidine derivative, its use as a medicinal product and corresponding treatment process
03/09/1993US5192535 Ophthalmic suspensions
03/09/1993US5192527 Method of reversing local anesthesia and reagent system therefor
03/09/1993US5192525 High affinity tamoxifen derivatives and uses thereof
03/09/1993US5192524 Captopril as a cancer chemopreventive agent
03/09/1993US5192357 Acrylate fungicides
03/09/1993CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers
03/09/1993CA1314287C Nitrogen-containing cycloalphatic compounds having an amino acid radical and a pyridine radical
03/09/1993CA1314286C Process for the preparation of eburnamenine derivatives
03/09/1993CA1314285C Pseudo-primycin complexes, components and acid addition salts thereof as well as a process for the preparation of same
03/09/1993CA1314283C Pyrazine diazohydroxide compounds and methods for their production and use
03/09/1993CA1314255C Antibiotic reuterin
03/09/1993CA1314233C Calcium supplements
03/09/1993CA1314232C Amino acid composition for parenteral nutritional support
03/09/1993CA1314231C Ifosphamide lyophilisate and process for its preparation
03/09/1993CA1314230C Mixtures for treating hypercholesterolemia
03/09/1993CA1314229C Treatment of lipoprotein disorders associated with cholesterol metabolism
03/09/1993CA1314228C Naphthyridine antianaerobic compounds
03/09/1993CA1314227C Pharmaceutical composition containing ketotifen
03/09/1993CA1314226C Anti-dementia agent
03/09/1993CA1314225C Controlled release agent for cetylpyridinium chloride
03/09/1993CA1314224C Antidiabetic agent
03/09/1993CA1314223C Composition for treating gastrointestinal disorders
03/09/1993CA1314222C Pharmaceutical composition for use against hypertension and congestive heart failure
03/09/1993CA1314221C Antiinfective composition containing non-ionic surfactant
03/09/1993CA1314220C Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
03/09/1993CA1314219C Use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs
03/09/1993CA1314218C Remote administration of hyaluronic acid to mammals